Announcements Trials

Browse Landscape

Status

Completed 32 Recruiting 14 Active not recruiting 7 Unknown 5 Withdrawn 3 Terminated 1 Not yet recruiting 1 No longer available 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Sarcoma 6 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Osteosarcoma 2 Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Stomach Neoplasms 1 Sarcoma, Synovial 1 Primary Myelofibrosis 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Insulinoma 1 Hypoglycemia 1 Hyperinsulinism 1 Hodgkin Disease 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fibrosarcoma 1 Endometrial Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Desmoid Tumors × Sarcoma × Clear all

NCT05041036 2026-05-08

Individual Patient Compassionate Use of Nirogacestat

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡